mario sznol, et al.
Published 10 years ago • 223 plays • Length 10:05Download video MP4
Download video MP3
Similar videos
-
5:19
mario sznol, yale cancer center, new haven, conn.
-
0:53
dr. mario sznol describes nivolumab in advanced melanoma
-
48:04
introduction & keynote - harnessing the immune system to treat cancer | presented by dr. mario sznol
-
1:47
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
3:12
dr. mario sznol reviews the efficacy of nivolumab in advanced melanoma
-
4:48
melanoma kills - the krista lake story
-
59:28
ocular melanoma: innovative treatments and beyond
-
6:10
nivolumab: a new standard-of-care
-
1:08
dr. sznol on managing patients beyond initial treatment in melanoma
-
1:00
dr. sznol on immune-related toxicities in melanoma
-
1:01
dr. sznol on managing toxicities in treatment of melanoma
-
1:29
dr. sznol on unanswered questions with immunotherapy in rcc
-
4:37
interview dr. sznol, asco 2014
-
1:17
dr. sznol on immunotherapy combinations for the treatment of melanoma
-
0:45
immunotherapy basics in melanoma
-
1:59
dr. sznol on combining nivolumab and ipilimumab for the treatment of advanced melanoma
-
1:22
dr. sznol discusses the combination of ipilimumab and nivolumab in melanoma
-
3:35
yale medicine skin cancer dr sznol
-
7:46
antoni ribas, et al.
-
1:02
dr. sznol on immunotherapy in patients with rcc
-
0:56
dr. sznol on the use of immunotherapy in melanoma
-
1:18
immunotherapy is a viable option despite toxicities